Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1981 2
1982 1
1983 1
1984 2
1986 2
1991 2
1995 1
1996 9
1997 3
1998 2
1999 2
2000 1
2001 3
2002 3
2003 7
2004 5
2005 5
2006 7
2007 6
2008 7
2009 13
2010 12
2011 13
2012 11
2013 15
2014 24
2015 39
2016 32
2017 35
2018 28
2019 16
2020 16
2021 34
2022 67
2023 90
2024 74
2025 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

551 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA).
Ioka T, Kanai M, Kobayashi S, Sakai D, Eguchi H, Baba H, Seo S, Taketomi A, Takayama T, Yamaue H, Takahashi M, Sho M, Kamei K, Fujimoto J, Toyoda M, Shimizu J, Goto T, Shindo Y, Yoshimura K, Hatano E, Nagano H; Kansai Hepatobiliary Oncology Group (KHBO). Ioka T, et al. Among authors: hatano e. J Hepatobiliary Pancreat Sci. 2023 Jan;30(1):102-110. doi: 10.1002/jhbp.1219. Epub 2022 Aug 9. J Hepatobiliary Pancreat Sci. 2023. PMID: 35900311 Free PMC article. Clinical Trial.
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.
Kudo M, Kawamura Y, Hasegawa K, Tateishi R, Kariyama K, Shiina S, Toyoda H, Imai Y, Hiraoka A, Ikeda M, Izumi N, Moriguchi M, Ogasawara S, Minami Y, Ueshima K, Murakami T, Miyayama S, Nakashima O, Yano H, Sakamoto M, Hatano E, Shimada M, Kokudo N, Mochida S, Takehara T. Kudo M, et al. Among authors: hatano e. Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19. Liver Cancer. 2021. PMID: 34239808 Free PMC article. Review.
A circulating subset of iNKT cells mediates antitumor and antiviral immunity.
Cui G, Shimba A, Jin J, Ogawa T, Muramoto Y, Miyachi H, Abe S, Asahi T, Tani-Ichi S, Dijkstra JM, Iwamoto Y, Kryukov K, Zhu Y, Takami D, Hara T, Kitano S, Xu Y, Morita H, Zhang M, Zreka L, Miyata K, Kanaya T, Okumura S, Ito T, Hatano E, Takahashi Y, Watarai H, Oike Y, Imanishi T, Ohno H, Ohteki T, Minato N, Kubo M, Holländer GA, Ueno H, Noda T, Shiroguchi K, Ikuta K. Cui G, et al. Among authors: hatano e. Sci Immunol. 2022 Oct 28;7(76):eabj8760. doi: 10.1126/sciimmunol.abj8760. Epub 2022 Oct 21. Sci Immunol. 2022. PMID: 36269840 Free article.
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).
Hasegawa K, Takemura N, Yamashita T, Watadani T, Kaibori M, Kubo S, Shimada M, Nagano H, Hatano E, Aikata H, Iijima H, Ueshima K, Ohkawa K, Genda T, Tsuchiya K, Torimura T, Ikeda M, Furuse J, Akahane M, Kobayashi S, Sakurai H, Takeda A, Murakami T, Motosugi U, Matsuyama Y, Kudo M, Tateishi R; committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan. Hasegawa K, et al. Among authors: hatano e. Hepatol Res. 2023 May;53(5):383-390. doi: 10.1111/hepr.13892. Epub 2023 Mar 10. Hepatol Res. 2023. PMID: 36826411
The Tokyo 2020 terminology of liver anatomy and resections: Updates of the Brisbane 2000 system.
Wakabayashi G, Cherqui D, Geller DA, Abu Hilal M, Berardi G, Ciria R, Abe Y, Aoki T, Asbun HJ, Chan ACY, Chanwat R, Chen KH, Chen Y, Cheung TT, Fuks D, Gotohda N, Han HS, Hasegawa K, Hatano E, Honda G, Itano O, Iwashita Y, Kaneko H, Kato Y, Kim JH, Liu R, López-Ben S, Morimoto M, Monden K, Rotellar F, Sakamoto Y, Sugioka A, Yoshiizumi T, Akahoshi K, Alconchel F, Ariizumi S, Benedetti Cacciaguerra A, Durán M, Garcia Vazquez A, Golse N, Miyasaka Y, Mori Y, Ogiso S, Shirata C, Tomassini F, Urade T, Wakabayashi T, Nishino H, Hibi T, Kokudo N, Ohtsuka M, Ban D, Nagakawa Y, Ohtsuka T, Tanabe M, Nakamura M, Tsuchida A, Yamamoto M. Wakabayashi G, et al. Among authors: hatano e. J Hepatobiliary Pancreat Sci. 2022 Jan;29(1):6-15. doi: 10.1002/jhbp.1091. Epub 2021 Dec 20. J Hepatobiliary Pancreat Sci. 2022. PMID: 34866349
Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023.
Akahoshi K, Shindoh J, Tanabe M, Ariizumi S, Eguchi S, Okamura Y, Kaibori M, Kubo S, Shimada M, Taketomi A, Takemura N, Nagano H, Nakamura M, Hasegawa K, Hatano E, Yoshizumi T, Endo I, Kokudo N. Akahoshi K, et al. Among authors: hatano e. Liver Cancer. 2024 Mar 29;13(6):0-10. doi: 10.1159/000538627. eCollection 2024 Dec. Liver Cancer. 2024. PMID: 39524972 Free PMC article.
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.
Shen YC, Liu TH, Nicholas A, Soyama A, Yuan CT, Chen TC, Eguchi S, Yoshizumi T, Itoh S, Nakamura N, Kosaka H, Kaibori M, Ishii T, Hatano E, Ogawa C, Naganuma A, Kakizaki S, Cheng CH, Lin PT, Su YY, Chuang CH, Lu LC, Wu CJ, Wang HW, Rau KM, Hsu CH, Lin SM, Huang YH, Hernandez S, Finn RS, Kudo M, Cheng AL. Shen YC, et al. Among authors: hatano e. J Clin Oncol. 2024 Dec;42(34):4060-4070. doi: 10.1200/JCO.24.00645. Epub 2024 Aug 28. J Clin Oncol. 2024. PMID: 39197119 Free PMC article.
Letter to the editor.
Nishino H, Seo S, Hatano E. Nishino H, et al. Among authors: hatano e. J Hepatobiliary Pancreat Sci. 2022 May;29(5):e46-e47. doi: 10.1002/jhbp.1125. Epub 2022 Mar 10. J Hepatobiliary Pancreat Sci. 2022. PMID: 35266312 No abstract available.
Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer.
Kawai M, Fukuda A, Ikeda M, Iimori K, Mizukoshi K, Iwane K, Yamakawa G, Omatsu M, Namikawa M, Sono M, Masuda T, Fukunaga Y, Nagao M, Araki O, Yoshikawa T, Ogawa S, Hiramatsu Y, Tsuda M, Maruno T, Nakanishi Y, Saur D, Tsuruyama T, Masui T, Hatano E, Seno H. Kawai M, et al. Among authors: hatano e. J Clin Invest. 2025 Jun 2;135(11):e177533. doi: 10.1172/JCI177533. eCollection 2025 Jun 2. J Clin Invest. 2025. PMID: 40454484 Free PMC article.
551 results